Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Freeman: Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic.... (0.11 sec) 

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral …

- nih.gov - Free from Publisher
R Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—Pooled analysis showed that pregabalin significantly reduced pain and
pain-related sleep interference associated with DPN (150, 300, and 600 mg/day
administered TID vs. placebo, all P ≤ 0.007). Only the 600 mg/day dosage ...
Cited by 19 - Related articles - All 9 versions

[PDF] Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy …


JC Arezzo, J Rosenstock, L LaMoreaux, L … - BMC Neurol, 2008 - biomedcentral.com
Page 1. ...
Cited by 7 - Related articles - View as HTML - All 7 versions

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, …


T Tölle, R Freynhagen, M Versavel, U … - European Journal of Pain, 2008 - Elsevier
Seven published, randomized, placebo-controlled clinical trials with pregabalin
have shown robust efficacy for relief of neuropathic pain from DPN and PHN. An
investigation of the efficacy and safety of twice daily pregabalin enrolled ...
Cited by 27 - Related articles - All 12 versions

Challenges in Design of Multicenter Trials

- diabetesjournals.org [PDF] 
PJ Dyck, JE Norell, H Tritschler, K Schuette, R … - Diabetes Care, 2007 - Am Diabetes Assoc
End points assessed longitudinally for change and monotonicity ... P ETER J. D
YCK , MD 1 J ANE E. N ORELL , BS 1 H ANS T RITSCHLER , PHD 2 K LEMENS S CHUETTE
, MSC 3 R USTEM S AMIGULLIN , MD 2 ... D AN Z IEGLER , MD 4 E DWARD J. B ...
Cited by 9 - Related articles - BL Direct - All 5 versions

Does treatment with duloxetine for neuropathic pain impact glycemic control?

- Free from Publisher
T Hardy, R Sachson, S Shen, M Armbruster, … - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—Duloxetine treatment resulted in modest increases in fasting plasma
glucose in short- and long-term studies (0.50 and 0.67 mmol/l, respectively).
A1C did not increase in placebo-controlled studies; however, a greater ...
Cited by 21 - Related articles - BL Direct - All 6 versions

[CITATION] Clarke, BF. Chronic and remitting painful diabetic polyneuropathy: correlations with …


RJ Young, DJ Ewing - Diabetes Care, 1988
Cited by 3 - Related articles

[CITATION] Diuretics, oral hypoglycemic agents, and insulin do not alter pregabalin pharmacokinetics


N Janiczek-Dolphin, BW Corrigan, HN … - Epilepsia, 2005
Cited by 3 - Related articles

[CITATION] High-affinity binding of pregabalin at alpha-2-delta subunits of voltage-gated calcium …


Z Li, S Donevan, CP Taylor… - Epilepsia, 2005
Cited by 3 - Related articles

Bodyweight gain under pregabalin therapy in epilepsy: Mitigation by counseling patients?


C Hoppe, M Rademacher, JM Hoffmann, D … - Seizure: European Journal of Epilepsy, 2008 - Elsevier
Randomized controlled trial on the effects of extended versus standard patient
counseling on the risk of bodyweight gain with 3- and 6-month follow-up
including a consecutive sample of adult outpatients with epilepsy eligible ...
Cited by 3 - Related articles - All 3 versions

Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo- …


RL Rauck, A Shaibani, V Biton, J Simpson, B … - The Clinical journal of pain, 2007 - journals.lww.com
Painful peripheral diabetic neuropathy (PDN) is a common complication of
diabetes affecting between 20% and 45%1,2 of patients with diabetes. Age,
duration of diabetes, and poor glycemic control are important risk factors. ...
Cited by 27 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google